Comparative clinical efficacy and safety of biosimilar ABP 959 and eculizumab reference product in patients with paroxysmal nocturnal hemoglobinuria. - Kulasekararaj A; Lanza F; Arvanitakis A; Langemeijer S; Chonat S; Tombak A; Hanes V; Cao J; Miller MJ; Colbert A; Shander B; Mytych DT; et al. (American journal of hematology, 2024)